Improve patients well being
Most chronic wounds are ulcers associated with ischemia, diabetes mellitus, venous stasis disease, or pressure. This poses a health problem with devastating consequences for patients’ quality of life.
INTERNATIONAL CONSENSUS DOCUMENT
Identifying and treating foot ulcers in patients with diabetes: saving feet, legs and lives
In this consensus document Sorbact® is recommended for prevention, management and treatment of infection and bioburden in diabetic foot ulcers (DFU) and pressure ulcers (PU). Advantages of Sorbact® include ”lack of bacterial resistance, its ability to attract antibiotic-resistant bacteria, non-allergenicity and no cytotoxicity”.
See tables 5, 6 and 7 – For wound dressings to consider for standard PU care, DFU care and as potential therapies if not part of local standard (pages 32, 33 and 40).Read publication